ABBV vs AMGN
By Alex · Tickerpine
AbbVie Inc. vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | AMGN |
|---|---|---|
| Price | $295.03 | $465.67 |
| Market cap | $521.50B | $251.89B |
| P/E ratio | 50.7 | 27.0 |
| ROE | — | 78.35% |
| Profit margin | 15.67% | 24.14% |
| Revenue growth | 10.30% | 8.50% |
| Dividend yield | 2.35% | 2.16% |
| Beta | 0.19 | 0.42 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs AMGN in plain English
- ABBV is the bigger company — about 2.1× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 27.0 vs 50.7).
- ABBV is growing revenue faster (10% vs 8%).
- ABBV has the higher dividend yield (2.35% vs 2.16%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.